References
Franceschi E, Bartolotti M, Paccapelo A, Marucci G, Agati R, Volpin L, Danieli D, Ghimenton C, Gardiman MP, Sturiale C, Poggi R, Mascarin M, Balestrini D, Masotto B, Brandes AA (2016) Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? J Neurooncol. doi:10.1007/s11060-016-2097-x
von Bueren AO, Friedrich C, von Hoff K, Kwiecien R, Muller K, Pietsch T, Warmuth-Metz M, Hau P, Benesch M, Kuehl J, Kortmann RD, Rutkowski S (2015) Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol. Eur J Cancer 51:2434–2443
Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer 49:893–903
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
von Bueren, A.O., Seidel, C. & Friedrich, C. Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?. J Neurooncol 129, 189–191 (2016). https://doi.org/10.1007/s11060-016-2159-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2159-0